Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

AVIENT CORP (AVNT) Announces Q4 2025 Results and Full-Year 2026 Guidance

Avient Corporation (NYSE: AVNT) has announced its fourth quarter and full-year 2025 results, along with its full-year 2026 financial guidance. Here are the key details from the press release:

  • Fourth quarter sales increased 2% to $761 million, while full-year sales increased 1% to $3,260 million. Foreign exchange had a favorable sales impact of 3% on the fourth quarter and 1% for the full year.

  • Fourth quarter GAAP EPS was $0.18, compared to $0.52 in the prior year. Full-year GAAP EPS was $0.89, compared to $1.84 in the prior year. However, fourth quarter adjusted EPS of $0.56 represents 14% growth over the prior year quarter, primarily driven by organic sales growth in the specialty engineered materials segment and company-wide productivity initiatives.

  • Full-year 2025 adjusted EPS of $2.82 represents an increase of 6% over the prior year, driven by adjusted EBITDA margin expansion of 50 basis points to 16.7% and lower interest expense.

  • The company reported strong operating cash flow generation of $302 million for the full-year 2025, which supported debt repayment of $150 million during the year.

  • For the full-year 2026, Avient expects adjusted EPS to range from $2.93 to $3.17, representing 4% to 12% growth over 2025.

  • The company also announced that demand conditions are expected to remain mixed as they start 2026. They are projecting first quarter adjusted EPS to be $0.81, reflecting 7% growth over the prior year quarter.

  • Avient expects to deliver free cash flow in excess of $200 million in 2026, which combined with its strong balance sheet cash position, will provide greater flexibility for cash deployment in the future.

The market has reacted to these announcements by moving the company's shares -0.97% to a price of $35.65. For the full picture, make sure to review AVIENT CORP's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS